[Behavior of the fasting blood sugar values in diabetics treated with oral and parenteral pentoxifylline].
Fasting blood sugar levels in hospitalized diabetics with peripheral vascular disease receiving pentoxifylline i.v. and p.o. did not-in comparison to a control group-show statistically significant changes during the observation period in well-controlled, stable diabetes mellitus (BS is less than or equal to 130 mg%); a decrease did occur in hyperglycemic patients. As a hypoglycemic drug effect was not demonstrable in the well-controlled patient-group, the decrease might well be attributable to improved dietary and antidiabetic care during the hospital-stay.
D000284:Administration, Oral; D001786:Blood Glucose / Q000032:analysis*; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy*; D005215:Fasting; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007263:Infusions, Parenteral; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage* / Q000627:therapeutic use; D013805:Theobromine / Q000031:analogs & derivatives*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013805:Theobromine; D010431:Pentoxifylline
Verhalten der Nüchternblutzucker-Werte bei Diabetikern unter oraler und parenteraler Pentoxifyllin-Medikation.